Clinical trial

Bufei Yishen Granule for Reducing Acute Exacerbation in GOLD Stage 3 or 4 COPD

NCT03976713

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2019-06-01

PhasePHASE3

Study timeline

Study start (estimated)2019-06-01Date precision: month

Registry last updated2019-06-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Chronic Obstructive Pulmonary Diseaseunresolved

Interventions

Bufei Yishen granuleDRUG

Placebo Bufei Yishen granuleDRUG

Tiotropium Bromide Powder for InhalationDRUG

Sponsors & collaborators

Henan University of Traditional Chinese Medicinelead sponsor

ShuGuang Hospitalcollaborator

Mapped research locations

ZhengzhouHenan, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03976713 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.